Loadman P - Search Results

1

In vitro 3D colon tumor penetrability of SRJ09, a new anti-cancer andrographolide analog.

Wong CC, Periasamy N, Sagineedu SR, Sidik S, Sumon SH, Loadman P, Phillips R, Lajis NH, Stanslas J. Wong CC, et al. Among authors: loadman p. Invest New Drugs. 2014 Oct;32(5):806-14. doi: 10.1007/s10637-014-0105-6. Epub 2014 May 31. Invest New Drugs. 2014. PMID: 24875131

2

Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours.

Phillips RM, Loadman PM, Cronin BP. Phillips RM, et al. Among authors: loadman pm. Br J Cancer. 1998 Jun;77(12):2112-9. doi: 10.1038/bjc.1998.355. Br J Cancer. 1998. PMID: 9649122 Free PMC article.

3

Inactivation of apaziquone by haematuria: implications for the design of phase III clinical trials against non-muscle invasive bladder cancer.

Phillips RM, Loadman PM, Reddy G. Phillips RM, et al. Cancer Chemother Pharmacol. 2019 Jun;83(6):1183-1189. doi: 10.1007/s00280-019-03812-7. Epub 2019 Mar 13. Cancer Chemother Pharmacol. 2019. PMID: 30868237 Free PMC article.

4

The relationship between the in vitro chemosensitivity of tumor cells and tumor response in vivo in an experimental tumor model.

Phillips RM, Bibby MC, Double JA, Loadman PM. Phillips RM, et al. Among authors: loadman pm. Int J Cell Cloning. 1991 Mar;9(2):144-54. doi: 10.1002/stem.5530090205. Int J Cell Cloning. 1991. PMID: 2037811 Free article.

5

Formation of DNA interstrand cross-links as a marker of Mitomycin C bioreductive activation and chemosensitivity.

Volpato M, Seargent J, Loadman PM, Phillips RM. Volpato M, et al. Eur J Cancer. 2005 Jun;41(9):1331-8. doi: 10.1016/j.ejca.2005.03.014. Eur J Cancer. 2005. PMID: 15869876

6

Experimental anti-tumor effects of flavone acetic acid (LM975).

Bibby MC, Double JA, Phillips RM, Loadman PM, Gummer JA. Bibby MC, et al. Among authors: loadman pm. Prog Clin Biol Res. 1988;280:243-6. Prog Clin Biol Res. 1988. PMID: 3174695 No abstract available.

7

Mathematical and computational models of drug transport in tumours.

Groh CM, Hubbard ME, Jones PF, Loadman PM, Periasamy N, Sleeman BD, Smye SW, Twelves CJ, Phillips RM. Groh CM, et al. Among authors: loadman pm. J R Soc Interface. 2014 Mar 12;11(94):20131173. doi: 10.1098/rsif.2013.1173. Print 2014 May 6. J R Soc Interface. 2014. PMID: 24621814 Free PMC article.

8

Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: implications for anticancer drug screening programs.

Phillips RM, Pearce J, Loadman PM, Bibby MC, Cooper PA, Swaine DJ, Double JA. Phillips RM, et al. Among authors: loadman pm. Cancer Res. 1998 Dec 1;58(23):5263-6. Cancer Res. 1998. PMID: 9850044

9

Pre-clinical evaluation of a novel chloroethylating agent, Clomesone.

Matthew AM, Phillips RM, Loadman PM, Bibby MC. Matthew AM, et al. Among authors: loadman pm. Br J Cancer. 1993 Mar;67(3):441-6. doi: 10.1038/bjc.1993.85. Br J Cancer. 1993. PMID: 8382507 Free PMC article.

10

Pharmacological approach towards the development of indolequinone bioreductive drugs based on the clinically inactive agent EO9.

Loadman PM, Bibby MC, Phillips RM. Loadman PM, et al. Br J Pharmacol. 2002 Nov;137(5):701-9. doi: 10.1038/sj.bjp.0704916. Br J Pharmacol. 2002. PMID: 12381684 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page